Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | 0.00% | 0.00% | 0.00% |
May. 19 | Genocea Biosciences, Inc. Went Out of Business | CI |
May. 11 | Liquidation Plan Approved for Genocea Biosciences, Inc. | CI |
Business Summary
Number of employees: 74
Sales per Business
USD in Million | 2020 | Weight | 2021 | Weight | Delta |
---|---|---|---|---|---|
Cancer Immunotherapies
100.0
%
| 1 | 100.0 % | 2 | 100.0 % | +20.75% |
Sales per region
USD in Million | 2020 | Weight | 2021 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 1 | 100.0 % | 2 | 100.0 % | +20.75% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Tech/Sci/R&D Officer | 52 | 07-02-28 | |
Girish Aakalu
PRN | Corporate Officer/Principal | - | 18-12-09 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Ken Bate
CHM | Chairman | 73 | 14-09-10 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 58,783,503 | 58,691,164 ( 99.84 %) | 0 | 99.84 % |
Company contact information
Genocea Biosciences, Inc.
Cambridge Discovery Park 100 Acorn Park Drive
02140, Cambridge
+617 876 8191
http://www.genocea.comSector
1st Jan change | Capi. | |
---|---|---|
0.00% | 58 | |
+9.30% | 46.03B | |
+52.73% | 44.55B | |
+7.15% | 40.8B | |
-8.78% | 28.25B | |
+18.68% | 27.71B | |
-21.92% | 18.82B | |
+14.62% | 13.91B | |
+31.85% | 12.43B | |
+4.47% | 10.81B |
- Stock
- Equities
- Stock Genocea Biosciences, Inc. - OTC Markets
- Company Genocea Biosciences, Inc.